Registered designated caregivers provisions modifications and increasing patient and cannabis plant limits expansion provision
SF4957 would expand Minnesota’s medical cannabis caregiver rules by increasing the number of patients a registered designated caregiver may serve and increasing the number of cannabis plants that may be cultivated for those patients. Under the bill, a caregiver could assist up to eight registered patients, and could cultivate up to 12 plants per patient, with no more than six mature or flowering plants per patient at one time. The bill also requires that caregiver-grown cannabis be kept in a locked, enclosed space, not visible from public view, and used only for the assigned patients. If a patient assigns cultivation rights to a caregiver, that patient could not also grow cannabis for personal medical use.
The bill also amends the caregiver registration provisions to align with the expanded cultivation authority. It would require the Office to register a caregiver for a patient who needs help administering medical cannabis, obtaining products or paraphernalia, or cultivating cannabis as allowed by law. A caregiver must be at least 18 years old, agree to possess the patient’s medical cannabis only for assistance purposes, and could serve no more than eight patients at a time, with patients in the same residence counting as one. The bill preserves the ability of a caregiver to also be enrolled as a patient in the registry program.
The bill’s impact would be to broaden access and flexibility within Minnesota’s medical cannabis program, especially for patients who rely on caregivers to obtain or grow cannabis. It would change state law governing caregiver registration and cultivation limits, and it would increase the maximum number of patients and plants associated with caregiver-assisted cultivation. It also clarifies that a patient who transfers cultivation rights to a caregiver gives up the right to grow for personal use.
Because there are no committee transcripts or recorded votes in the provided materials, there is little direct evidence of legislative debate or formal support/opposition. Based on the bill text, the measure appears generally pro-access and pro-expansion for medical cannabis patients and caregivers, with the main policy tradeoff being greater caregiver capacity versus tighter rules preventing duplicate cultivation by both the patient and caregiver. Any contention would likely center on whether the higher patient and plant limits are appropriate and how the expanded cultivation authority should be regulated.
SF4957 would amend Minnesota’s medical cannabis statutes to expand the authority of registered designated caregivers, increasing the number of patients a caregiver may serve from six to eight and allowing cultivation of up to 12 plants per patient, subject to a six-plant mature/flowering cap per patient. It would also revise registration requirements and cultivation rules in Minnesota Statutes sections 342.09 and 342.52, affecting the Office’s administration of the registry program, patients who rely on caregivers, and caregivers who cultivate or obtain medical cannabis on behalf of patients.
No committee testimony or vote history was provided, so there is no recorded public sentiment in the materials. The bill’s text suggests a generally supportive, expansion-oriented approach to medical cannabis access, with the policy goal of making caregiver assistance more flexible for patients who need help obtaining or cultivating cannabis. The principal sentiment implied by the bill is favorable toward patient access, while still preserving regulatory controls on storage, visibility, and exclusive use for assigned patients.
The main points of potential contention are the increased patient cap per caregiver, the higher plant limits, and the broader cultivation authority granted to caregivers. Supporters would likely view the bill as improving access for patients who cannot easily manage cultivation or procurement themselves, while critics may worry about enforcement, diversion, and whether the expanded limits could exceed what is necessary for medical use. Another likely issue is the rule that a patient who assigns cultivation rights to a caregiver may not also cultivate for personal use, which could be seen as a reasonable anti-duplication safeguard or as an unnecessary restriction depending on perspective.